{"name": "Xphase Pharmaceuticals",
 "permalink": "xphase-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/xphase-pharmaceuticals",
 "homepage_url": "http://xphasepharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@xphasepharma.com",
 "phone_number": " +1-416-238-4463",
 "description": "drug development ",
 "created_at": "Fri Sep 04 13:30:22 UTC 2009",
 "updated_at": "Fri Sep 04 13:32:40 UTC 2009",
 "overview": "\u003Cp\u003EXPhase Pharmaceuticals Inc., a drug development and regulatory consulting company, engages in the early stage clinical development of pharmaceuticals in Canada and internationally. It offers drug development services, such as pre-clinical development to IND submission of new chemical entities, study designs and protocol preparation, and formulation, analytical, and manufacturing process development for small molecule and large molecule drug candidates.\u003C/p\u003E\n\n\u003Cp\u003EThe company provides its services to small and medium pharmaceutical and biotechnology companies in the United States, European Union, Central Eastern European, and Asian countries. XPhase Pharmaceuticals Inc. was founded in 2007 and is based in Toronto, Canada. As of August 11, 2009, XPhase Pharmaceuticals Inc. operates as a subsidiary of Pacgen Biopharmaceuticals Corporation.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       90],
      "assets/images/resized/0005/8746/58746v1-max-150x150.jpg"],
     [[162,
       98],
      "assets/images/resized/0005/8746/58746v1-max-250x250.jpg"],
     [[162,
       98],
      "assets/images/resized/0005/8746/58746v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 310000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "http://www.tradingmarkets.com/.site/news/Stock%20News/2480679/",
   "source_description": "Pacgen Biopharmaceuticals acquires Xphase Pharmaceuticals",
   "acquired_year": 2009,
   "acquired_month": 8,
   "acquired_day": 13,
   "acquiring_company":
    {"name": "Pacgen Biopharmaceuticals",
     "permalink": "pacgen-biopharmaceuticals",
     "image":
      {"available_sizes":
        [[[150,
           25],
          "assets/images/resized/0005/8744/58744v1-max-150x150.jpg"],
         [[250,
           42],
          "assets/images/resized/0005/8744/58744v1-max-250x250.jpg"],
         [[339,
           58],
          "assets/images/resized/0005/8744/58744v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "4700 Keele Street, 190 Albany",
    "address2": "Suite 215",
    "zip_code": "M3J 1P3",
    "city": "Toronto",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[144,
        150],
       "assets/images/resized/0005/8747/58747v1-max-150x150.jpg"],
      [[241,
        250],
       "assets/images/resized/0005/8747/58747v1-max-250x250.jpg"],
      [[434,
        450],
       "assets/images/resized/0005/8747/58747v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}